The Safety and Effectiveness of FIAC in the Treatment of Cytomegalovirus (CMV) in Patients With AIDS

NCT00000981 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

78

Enrollment

NIH

Sponsor class

Conditions

Cytomegalovirus Infections
HIV Infections

Interventions

DRUG: Fiacitabine

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)

Collaborators

[object Object]